BackComera Life Sciences Holdings- Warrants (19/05/2027) Overview
Comera Life Sciences Holdings Inc - Warrants (19/05/2027)

Comera Life Sciences Holdings- Warrants (19/05/2027) Debt to Equity

Valuation check: CMRAW's debt-to-equity ratio is -0.33, below the sector sector average of 0.2.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

-0.33

Debt to Equity

-0.33

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) FAQ

As of the most recent data, CMRAW shows a debt-to-equity ratio of -0.33. That is below the sector sector average of 0.2. Scroll down for historical charts and peer comparison views.

The its sector sector average debt-to-equity ratio is about 0.2. Comera Life Sciences Holdings- Warrants (19/05/2027) is at -0.33, which is lower that average. That is roughly 265.0% below the sector mean. Use the comparison chart on this page to see how CMRAW stacks up against individual peers as well.

Investors watch CMRAW's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Comera Life Sciences Holdings- Warrants (19/05/2027)'s latest reading is -0.33. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Comera Life Sciences Holdings- Warrants (19/05/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently -0.33) with ownership activity and broader fundamentals.